L, O., M, P., C, C., P, G., AV, C., F, C., & N, C. (2021). Risk and Prevention of Hepatitis B Virus Reactivation during Immunosuppression for Non-Oncological Diseases. Journal of clinical medicine, 10(21), . https://doi.org/10.3390/jcm10215201
Chicago Style (17th ed.) CitationL, Onorato, Pisaturo M, Camaioni C, Grimaldi P, Codella AV, Calò F, and Coppola N. "Risk and Prevention of Hepatitis B Virus Reactivation During Immunosuppression for Non-Oncological Diseases." Journal of Clinical Medicine 10, no. 21 (2021). https://doi.org/10.3390/jcm10215201.
MLA (9th ed.) CitationL, Onorato, et al. "Risk and Prevention of Hepatitis B Virus Reactivation During Immunosuppression for Non-Oncological Diseases." Journal of Clinical Medicine, vol. 10, no. 21, 2021, https://doi.org/10.3390/jcm10215201.